Genotypic-phenotypic features and enzyme replacement therapy outcome in patients with mucopolysaccharidosis VI from Turkey

Author:

Kılıç Mustafa1ORCID,Dursun Ali2,Coşkun Turgay2,Tokatlı Ayşegül2,Özgül Rıza K.2,Yücel-Yılmaz Didem2,Karaca Mehmet3,Doğru Deniz4,Alehan Dursun5,Kadayıfçılar Sibel6,Genç Aydan7,Turan-Dizdar Handan7,Gönüldaş Burhanettin8,Savcı Sema9,Sağlam Melda9,Aksoy Cemalettin10,Arslan Umut11,Sivri Hatice-Serap2

Affiliation:

1. Sami Ulus Children Hospital; Division of Metabolism; Ankara Turkey

2. Hacettepe University Children Hospital; Division of Metabolism; Ankara Turkey

3. Faculty of Science and Arts, Department of Biology; Aksaray University; Aksaray Turkey

4. Hacettepe University Children Hospital; Division of Pediatric Pulmonology; Ankara Turkey

5. Hacettepe University Children Hospital; Division of Pediatric Cardiology; Ankara Turkey

6. Faculty of Medicine, Department of Ophthalmology; Hacettepe University; Ankara Turkey

7. Faculty of Medicine, Department of Ear Nose Throat, Division of Audiology; Hacettepe University; Ankara Turkey

8. Faculty of Medicine, Department of Ear Nose Throat; Hacettepe University; Ankara Turkey

9. Faculty of Health Sciences, Department of Physiotheraphy and Rehabilitation; Hacettepe University; Ankara Turkey

10. Faculty of Medicine, Department of Orthopaedics and Traumatology; Hacettepe University; Ankara Turkey

11. Faculty of Medicine, Department of Biostatistics; Hacettepe University; Ankara Turkey

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Reference45 articles.

1. Clinical and laboratorial study of 19 cases of mucopolysaccharidoses;Albano;Revista do Hospital Das Clinicas; Faculdade de Medicina da Universidade de Sao Paulo,2000

2. Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI;Azevedo;Clinical Genetics,2004

3. Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase;Brands;Orphanet Journal of Rare Diseases,2013

4. Up to five years’ experience with 11 mucopolysaccharidosis type VI patients;Brands;Molecular Genetics and Metabolism,2013

5. Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme(R)) therapy;Braunlin;Journal of Inherited Metabolic Disease,2013

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3